Insulin Effects on Glucose Metabolism, Memory, and Plasma Amyloid Precursor Protein in Alzheimer's Disease Differ According to Apolipoprotein-E Genotype

: Higher fasting plasma insulin levels and reduced CSF‐to‐plasma insulin‐ratios, suggestive of insulin resistance, have been observed in patients with Alzheimer's disease (AD) who do not possess an apolipoprotein E (ApoE)‐ɛ4 allele. Insulin has also been implicated in processing of β‐amyloid an...

Full description

Saved in:
Bibliographic Details
Published in:Annals of the New York Academy of Sciences 2000-04, Vol.903 (1), p.222-228
Main Authors: CRAFT, SUZANNE, ASTHANA, SANJAY, SCHELLENBERG, GERARD, BAKER, LAURA, CHERRIER, MONIQUE, BOYT, ADAM A., MARTINS, RALPH N., RASKIND, MURRAY, PESKIND, ELAINE, PLYMATE, STEPHEN
Format: Article
Language:English
Subjects:
Adult
Aged
Alzheimer Disease - genetics
Alzheimer Disease - physiopathology
Alzheimer Disease - psychology
Amyloid beta-Protein Precursor - blood
Apolipoprotein E4
Apolipoproteins E - genetics
Blood Glucose - drug effects
Blood Glucose - metabolism
Female
Genotype
Glucose Clamp Technique
Humans
Insulin - blood
Insulin - pharmacology
Insulin Resistance
Male
Memory - physiology
Reference Values
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:: Higher fasting plasma insulin levels and reduced CSF‐to‐plasma insulin‐ratios, suggestive of insulin resistance, have been observed in patients with Alzheimer's disease (AD) who do not possess an apolipoprotein E (ApoE)‐ɛ4 allele. Insulin has also been implicated in processing of β‐amyloid and amyloid precursor protein (APP). We examined the effects of intravenous insulin administration while maintaining euglycemia on insulin‐mediated glucose disposal, memory, and plasma APP in patients with AD and normal adults of varying ApoE genotypes. AD subjects without an ɛ4 allele had significantly lower insulin‐mediated glucose disposal rates than did AD patients with an ɛ4 allele (p < 0.03) or than did normal adults without an ɛ4 allele (p < 0.02). AD subjects without an ɛ4 allele also showed significant memory facilitation with insulin administration (p < 0.04), whereas the AD‐ɛ4 group did not. Insulin reduced APP levels for AD patients without an ApoE ɛ4 allele, but raised APP for AD patients with an ApoE ɛH4 allele These results document ApoE‐related differences in insulin metabolism in AD that may relate to disease pathogenesis.
ISSN:0077-8923
1749-6632
DOI:10.1111/j.1749-6632.2000.tb06371.x